Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
Below are some highlights from second quarter earnings reports recently released by biologics and biosimilar companies. ..Coherus reported that it has cash and cash equivalents of $118.3 million as of June 30, 2017 and...more